Matches in Nanopublications for { ?s ?p "[The results of this study on familial and unselected breast, ovarian, colorectal, and prostate cancer patients suggest that RAD51D is primarily a moderate penetrance susceptibility gene for ovarian cancer, with clinical significance for the carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_assertion description "[The results of this study on familial and unselected breast, ovarian, colorectal, and prostate cancer patients suggest that RAD51D is primarily a moderate penetrance susceptibility gene for ovarian cancer, with clinical significance for the carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_provenance.
- assertion description "[The results of this study on familial and unselected breast, ovarian, colorectal, and prostate cancer patients suggest that RAD51D is primarily a moderate penetrance susceptibility gene for ovarian cancer, with clinical significance for the carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The results of this study on familial and unselected breast, ovarian, colorectal, and prostate cancer patients suggest that RAD51D is primarily a moderate penetrance susceptibility gene for ovarian cancer, with clinical significance for the carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP986302.RACUdph79GayRhyA-bLasIgWij0coT5c87cuGbiQxbRk4130_assertion description "[The results of this study on familial and unselected breast, ovarian, colorectal, and prostate cancer patients suggest that RAD51D is primarily a moderate penetrance susceptibility gene for ovarian cancer, with clinical significance for the carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986302.RACUdph79GayRhyA-bLasIgWij0coT5c87cuGbiQxbRk4130_provenance.
- NP664149.RAgQLiiMipJ9u4jpObz-OFCdFhAylxRhKy8NATV1olO-Y130_assertion description "[The results of this study on familial and unselected breast, ovarian, colorectal, and prostate cancer patients suggest that RAD51D is primarily a moderate penetrance susceptibility gene for ovarian cancer, with clinical significance for the carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664149.RAgQLiiMipJ9u4jpObz-OFCdFhAylxRhKy8NATV1olO-Y130_provenance.
- NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_assertion description "[The results of this study on familial and unselected breast, ovarian, colorectal, and prostate cancer patients suggest that RAD51D is primarily a moderate penetrance susceptibility gene for ovarian cancer, with clinical significance for the carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_provenance.
- NP986301.RAyrnlRGVYOoiNiZEc_W1WDScOXlonghmq99FvM-dJcDg130_assertion description "[The results of this study on familial and unselected breast, ovarian, colorectal, and prostate cancer patients suggest that RAD51D is primarily a moderate penetrance susceptibility gene for ovarian cancer, with clinical significance for the carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986301.RAyrnlRGVYOoiNiZEc_W1WDScOXlonghmq99FvM-dJcDg130_provenance.